Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
Malaria journal; 197 (13), 2014
Ano de publicação: 2014
: There is limited data available regarding safety profile of artemisinins in early pregnancy. They are,
therefore, not recommended by WHO as a first-line treatment for malaria in first trimester due to associated
embryo-foetal toxicity in animal studies. The study assessed birth outcome among pregnant women inadvertently
exposed to artemether-lumefantrine (AL) during first trimester in comparison to those of women exposed to other
anti-malarial drugs or no drug at all during the same period of pregnancy.